Audrey Jackson is a senior fellow with the CSIS Global Health Policy Center. She focuses on global infectious diseases policy, including for tuberculosis, malaria, and antimicrobial resistance. Prior to CSIS, she managed the antimicrobial resistance policy portfolio for the U.S. Department of Health and Human Services Office of Global Affairs. In that role, she participated in the development of the National Action Plan for Combating Multidrug-Resistant Tuberculosis and helped to advance U.S. positions on antimicrobial resistance in various multilateral settings, including the World Health Organization and the G7. Earlier, as director of science policy at the Infectious Diseases Society of America, Jackson led a broad portfolio of infectious disease issue areas, including training of research scientists; research and development of antimicrobials, vaccines, and in vitro diagnostics; public health preparedness and response strategies for pandemic influenza and other emerging infectious diseases; and combating antimicrobial resistance. She has published extensively in policy and in scientific journals, including Nature. Prior to her career in health policy, she worked as a management consultant, primarily for clients in the pharmaceutical industry. Jackson received an M.S. and Ph.D. in microbiology from Yale University and an A.B. magna cum laude in biology from Harvard University.